Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$36.54 - $48.66 $6,211 - $8,272
170 Added 293.1%
228 $10,000
Q1 2020

May 07, 2020

SELL
$41.6 - $63.4 $3,868 - $5,896
-93 Reduced 61.59%
58 $3,000
Q4 2019

Jan 30, 2020

SELL
$53.85 - $65.27 $2,369 - $2,871
-44 Reduced 22.56%
151 $9,000
Q3 2019

Oct 30, 2019

BUY
$59.06 - $72.15 $8,091 - $9,884
137 Added 236.21%
195 $12,000
Q1 2019

May 07, 2019

BUY
$52.92 - $81.17 $3,069 - $4,707
58 New
58 $5,000
Q4 2018

Feb 05, 2019

SELL
$43.37 - $59.54 $2,515 - $3,453
-58 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$42.88 - $53.7 $7,289 - $9,129
-170 Reduced 74.56%
58 $3,000
Q2 2018

Jul 30, 2018

SELL
$40.53 - $50.7 $11,024 - $13,790
-272 Reduced 54.4%
228 $10,000
Q4 2017

Feb 09, 2018

BUY
$50.3 - $64.39 $25,150 - $32,195
500
500 $25,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.16B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.